OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder
Dimy Fluyau, Vasanth Kattalai Kailasam, Christopher G. Pierre
Journal of Psychopharmacology (2023) Vol. 37, Iss. 2, pp. 155-163
Closed Access | Times Cited: 13

Showing 13 citing articles:

Overview of Alcohol Use Disorder
Henry R. Kranzler
American Journal of Psychiatry (2023) Vol. 180, Iss. 8, pp. 565-572
Closed Access | Times Cited: 28

Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
João P. De Aquino, Matthew E. Sloan, Julio C. Nunes, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 391-402
Closed Access | Times Cited: 9

Medications for treating alcohol use disorder: A narrative review
Henry R. Kranzler, Emily E. Hartwell
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 7, pp. 1224-1237
Closed Access | Times Cited: 17

A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Muhammet Celik, Mark S. Gold, Brian Fuehrlein
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 294-294
Open Access | Times Cited: 7

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial
Kirsten C. Morley, Henry R. Kranzler, Natasha Luquin, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 403-411
Closed Access | Times Cited: 7

Mood Stabilizers of First and Second Generation
Janusz Rybakowski
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 741-741
Open Access | Times Cited: 15

Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender
Dylan Kirsch, Malia A. Belnap, Elizabeth M. Burnette, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 1, pp. 81-93
Closed Access | Times Cited: 5

Addiction and Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management
David Hudson, Nisha Howarth, Francisco Idalsoaga, et al.
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 110-122
Closed Access | Times Cited: 2

EFFICACY OF MEDICATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDER (AUD): A SYSTEMATIC REVIEW AND META-ANALYSIS CONSIDERING BASELINE AUD SEVERITY
Roberta Agabio, Hugo López‐Pelayo, Pol Bruguera, et al.
Pharmacological Research (2024) Vol. 209, pp. 107454-107454
Open Access | Times Cited: 2

Screening and Treatment of Alcohol Use Disorder in China: Current Situation and Recommendations for Improvement
Yi‐lang Tang, Jing Liu, Wei Hao
Current Addiction Reports (2024) Vol. 11, Iss. 5, pp. 877-885
Closed Access | Times Cited: 1

Comparative effects of topiramate and naltrexone on neural activity during anticipatory anxiety in individuals with alcohol use disorder
Gezelle Dali, Warren Logge, Henry R. Kranzler, et al.
Alcohol and Alcoholism (2024) Vol. 60, Iss. 1
Open Access

Modern pharmacotherapy guidance for treating alcohol use disorders
Michael Soyka, Susanne Rösner
Expert Opinion on Pharmacotherapy (2024)
Closed Access

Evidence of subgroup differences in meta‐analyses evaluating medications for alcohol use disorder: An umbrella review
Joshua D. Wallach, Laura Glick, Ralitza Gueorguieva, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 48, Iss. 1, pp. 5-15
Closed Access | Times Cited: 1

Page 1

Scroll to top